share_log

Strong Week for AdaptHealth (NASDAQ:AHCO) Shareholders Doesn't Alleviate Pain of Three-year Loss

Strong Week for AdaptHealth (NASDAQ:AHCO) Shareholders Doesn't Alleviate Pain of Three-year Loss

adapthealth股东强劲的一周并不能减轻三年来的损失之痛
Simply Wall St ·  11/26 22:26

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term AdaptHealth Corp. (NASDAQ:AHCO) shareholders, since the share price is down 50% in the last three years, falling well short of the market return of around 25%. But it's up 5.7% in the last week.

为了证明选择个股的努力是有价值的,值得努力超越市场指数基金的回报。但选股的风险在于你可能会购买表现不佳的公司。不幸的是,这对于长期的adapthealth公司(纳斯达克:AHCO)股东来说一直是个问题,因为股价在过去三年中下跌了50%,远远低于大约25%的市场回报。然而,在过去一周中股价上涨了5.7%。

While the last three years has been tough for AdaptHealth shareholders, this past week has shown signs of promise. So let's look at the longer term fundamentals and see if they've been the driver of the negative returns.

尽管过去三年对adapthealth股东而言很艰难,但上周显示出了一些希望。因此,让我们看看长期的基本面,看看它们是否是负回报的驱动因素。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

在他的文章《格雷厄姆和道德斯维尔的超级投资者》中,沃伦·巴菲特描述了股价并不总是理性反映公司价值的方式。检查市场情绪如何随时间变化的一种方式是查看公司股价与每股收益(EPS)之间的互动。

We know that AdaptHealth has been profitable in the past. On the other hand, it reported a trailing twelve months loss, suggesting it isn't reliably profitable. Other metrics might give us a better handle on how its value is changing over time.

我们知道adapthealth过去是盈利的。另一方面,它报告了过去十二个月的亏损,这表明它并不可靠地盈利。其他指标可能会让我们更好地了解其价值随时间的变化。

Revenue is actually up 11% over the three years, so the share price drop doesn't seem to hinge on revenue, either. It's probably worth investigating AdaptHealth further; while we may be missing something on this analysis, there might also be an opportunity.

营业收入在过去三年中实际上增长了11%,因此股价下跌似乎并不依赖于营业收入。可能值得进一步调查adapthealth;尽管我们可能在这次分析中遗漏了一些东西,但也可能存在机会。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下面的图表显示了收益和营收随时间的变化情况(通过单击图像揭示确切的值)。

big
NasdaqCM:AHCO Earnings and Revenue Growth November 26th 2024
纳斯达克CM:AHCO 每股收益和营业收入增长 2024年11月26日

This free interactive report on AdaptHealth's balance sheet strength is a great place to start, if you want to investigate the stock further.

这份关于adapthealth资产负债表强度的免费互动报告是一个很好的开始,如果你想进一步研究这只股票。

A Different Perspective

另一种看法

AdaptHealth provided a TSR of 16% over the last twelve months. But that return falls short of the market. The silver lining is that the gain was actually better than the average annual return of 1.1% per year over five year. This could indicate that the company is winning over new investors, as it pursues its strategy. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we've spotted with AdaptHealth .

adapthealth在过去十二个月提供了16%的总股东回报率。但这一回报低于市场。幸运的是,这一收益实际上优于过去五年年均1.1%的回报。这可能表明该公司正在赢得新的投资者,因为它在追求其策略时表现出色。虽然考虑市场状况对股票价格的不同影响是值得的,但还有其他因素更为重要。为此,你应该知道我们发现的adapthealth的一个警告信号。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

当然,您可能通过在其他地方寻找会找到一笔极好的投资。因此,请查看我们预计会增长收入的公司免费名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发